Neogen Statistics
Total Valuation
Neogen has a market cap or net worth of $1.16 billion. The enterprise value is $1.92 billion.
Important Dates
The next estimated earnings date is Tuesday, July 29, 2025, before market open.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Neogen has 217.04 million shares outstanding. The number of shares has increased by 0.15% in one year.
| Current Share Class | 217.04M |
| Shares Outstanding | 217.04M |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 0.37% |
| Owned by Institutions (%) | 120.53% |
| Float | 201.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 14.81 |
| PS Ratio | 1.28 |
| Forward PS | 1.27 |
| PB Ratio | 0.43 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 16.90 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.12 |
| EV / EBITDA | 12.11 |
| EV / EBIT | 47.26 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.34.
| Current Ratio | 3.91 |
| Quick Ratio | 2.04 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 5.63 |
| Debt / FCF | n/a |
| Interest Coverage | 0.56 |
Financial Efficiency
Return on equity (ROE) is -16.71% and return on invested capital (ROIC) is 0.67%.
| Return on Equity (ROE) | -16.71% |
| Return on Assets (ROA) | 0.59% |
| Return on Invested Capital (ROIC) | 0.67% |
| Return on Capital Employed (ROCE) | 1.04% |
| Revenue Per Employee | $310,592 |
| Profits Per Employee | -$166,357 |
| Employee Count | 2,917 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 2.39 |
Taxes
| Income Tax | -23.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.77% in the last 52 weeks. The beta is 1.78, so Neogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | -64.77% |
| 50-Day Moving Average | 5.57 |
| 200-Day Moving Average | 10.41 |
| Relative Strength Index (RSI) | 50.04 |
| Average Volume (20 Days) | 6,654,690 |
Short Selling Information
The latest short interest is 25.07 million, so 11.55% of the outstanding shares have been sold short.
| Short Interest | 25.07M |
| Short Previous Month | 26.74M |
| Short % of Shares Out | 11.55% |
| Short % of Float | 12.45% |
| Short Ratio (days to cover) | 4.79 |
Income Statement
In the last 12 months, Neogen had revenue of $906.00 million and -$485.26 million in losses. Loss per share was -$2.24.
| Revenue | 906.00M |
| Gross Profit | 442.00M |
| Operating Income | 40.70M |
| Pretax Income | -14.31M |
| Net Income | -485.26M |
| EBITDA | 158.78M |
| EBIT | 40.70M |
| Loss Per Share | -$2.24 |
Full Income StatementBalance Sheet
The company has $127.71 million in cash and $894.26 million in debt, giving a net cash position of -$766.55 million or -$3.53 per share.
| Cash & Cash Equivalents | 127.71M |
| Total Debt | 894.26M |
| Net Cash | -766.55M |
| Net Cash Per Share | -$3.53 |
| Equity (Book Value) | 2.66B |
| Book Value Per Share | 12.26 |
| Working Capital | 410.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $68.45 million and capital expenditures -$112.71 million, giving a free cash flow of -$44.26 million.
| Operating Cash Flow | 68.45M |
| Capital Expenditures | -112.71M |
| Free Cash Flow | -44.26M |
| FCF Per Share | -$0.20 |
Full Cash Flow StatementMargins
Gross margin is 48.79%, with operating and profit margins of 4.49% and -53.56%.
| Gross Margin | 48.79% |
| Operating Margin | 4.49% |
| Pretax Margin | -56.10% |
| Profit Margin | -53.56% |
| EBITDA Margin | 17.53% |
| EBIT Margin | 4.49% |
| FCF Margin | n/a |
Dividends & Yields
Neogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.15% |
| Shareholder Yield | -0.15% |
| Earnings Yield | -41.95% |
| FCF Yield | -3.83% |
Dividend DetailsAnalyst Forecast
The average price target for Neogen is $7.50, which is 40.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.50 |
| Price Target Difference | 40.71% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 2.26% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 7, 2021. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2021 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Neogen has an Altman Z-Score of 1.76 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.76 |
| Piotroski F-Score | 5 |
